Get access to our best features

Get access to our best features

NCI-led clinical trial results in the first approval of a treatment for advanced alveolar soft part sarcoma

Summary by Ground News
The immunotherapy drug atezolizumab (Tecentriq) was recently approved by the U.S. Food and Drug Administration. About 80 people in the United States are diagnosed with ASPS every year. About a third of patients responded to the treatment with some degree of tumor shrinkage.
Published 5 months ago

News Articles


Similar News Topics

Show All
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

67% of the sources are Center
National Institutes of Health (NIH)…
News Medical
Medical Xpress
L 33%
C 67%
See less detail